Stay updated on Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.

Latest updates to the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision label updated from v3.4.0 to v3.4.1 on the page. This is a minor update that does not affect the displayed study details or workflow.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedAdded new study locations in Canada (Nova Scotia and Quebec) under the Locations section. The HHS Vulnerability Disclosure link was removed from the footer as part of the v3.3.3 update.SummaryDifference0.3%

- Check77 days agoChange DetectedFatty Liver Disease was added as a related topic and How to Prevent Diabetes was removed as a related topic.SummaryDifference0.1%

- Check91 days agoChange DetectedPublications section now includes a note that items are automatically filled from PubMed and may not all pertain to the study, and the page revision has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of IONIS-DGAT2Rx in Type 2 Diabetes Clinical Trial page.